Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

NCT05342194 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

480

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma

Interventions

DRUG: Toripalimab
DRUG: Lenvatinib mesylate capsules
DRUG: Placebo IV
DRUG: Oral placebo
DRUG: Oxaliplatin for injection
DRUG: Gemcitabine hydrochloride
DRUG: Cisplatin

Sponsor

Shanghai Junshi Bioscience Co., Ltd.